We are live on ! Find out more
CMPS

Compass Pathways

126 hedge funds and large institutions have $201M invested in Compass Pathways in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 20 increasing their positions, 31 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

241% more call options, than puts

Call options by funds: $5.93M | Put options by funds: $1.74M

67% more funds holding in top 10

Funds holding in top 10: 35 (+2)

62% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 21

22% more capital invested

Capital invested by funds: $165M → $201M (+$36.3M)

12% more funds holding

Funds holding: 113126 (+13)

1.12% more ownership

Funds ownership: 36.01%37.12% (+1.1%)

35% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 31

Holders
126
Holders Change
+13
Holders Change %
+11.5%
% of All Funds
1.83%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.07%
New
34
Increased
20
Reduced
31
Closed
21
Calls
$5.93M
Puts
$1.74M
Net Calls
+$4.19M
Net Calls Change
+$891K

CMPS Hedge Fund Activity: Q4 2023 in Review

126 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Compass Pathways (CMPS) for Q4 2023, worth a combined $201M — up 22% from $165M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new CMPS positions and 21 closed out — a net gain of 13 holders — while 20 added to existing stakes and 31 trimmed.

The largest buyer was Paradigm Biocapital Advisors, adding an estimated $5.87M. The largest seller was AGF Management, exiting entirely with an estimated $7.56M sold.

  • 126 institutional investors held Compass Pathways (CMPS) as of Q4 2023, up from 113 in Q3 2023.
  • Funds reported $201M of Compass Pathways stock for Q4 2023, up 22% quarter-over-quarter.
  • 34 funds opened new Compass Pathways positions in Q4 2023 and 21 closed out, a net change of +13 holders.
  • The largest Compass Pathways buyer in Q4 2023 was Paradigm Biocapital Advisors, an estimated $5.87M added.
  • The largest Compass Pathways seller in Q4 2023 was AGF Management, an estimated $7.56M sold.

Based on aggregated 13F filings for Q4 2023.